Highlighted Transactions



Daiya Foods Inc.

On August 31, 2017, Otsuka Pharmaceutical Co., Ltd. ("Otsuka"), a wholly owned subsidiary of Otsuka Holdings Co., Ltd. (TSE: 4578), completed its previously announced acquisition of Daiya Foods Inc., a privately held Vancouver-based company specializing in the manufacture of plant-based foods, for 405 million Canadian dollars.

Piper Jaffray served as exclusive financial advisor to Daiya Foods Inc.

Client Description

Founded in 2008, Daiya was among the pioneers in developing delicious, plant-based cheese alternatives. The company has demonstrated its brand extendibility, now offering a wide range of successful plant-based food products that are dairy-, gluten- and soy-free. Daiya's growing product line includes refrigerated and frozen items and shelf-stable products. The company sells its products in more than 25,000 grocery stores in the U.S., as well as internationally in Australia, Sweden, Mexico and Hong Kong, among others.

Counterparty Description

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: "People creating new products for better health worldwide." Otsuka researches, develops, manufactures and markets pharmaceutical products for disease treatment and nutraceutical products for maintaining everyday health. Otsuka is a wholly owned subsidiary of Tokyo-based Otsuka Holdings Co., Ltd., which had consolidated sales of approximately 1,196 billion Japanese yen ($10.3 billion USD) in 2016 and approximately 45,000 employees worldwide.